These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19950406)

  • 1. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.
    Collins LC; Achacoso N; Nekhlyudov L; Fletcher SW; Haque R; Quesenberry CP; Puligandla B; Alshak NS; Goldstein LC; Gown AM; Schnitt SJ; Habel LA
    Am J Surg Pathol; 2009 Dec; 33(12):1802-8. PubMed ID: 19950406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.
    Goldstein NS; Vicini FA; Kestin LL; Thomas M
    Cancer; 2000 Jun; 88(11):2553-60. PubMed ID: 10861433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nomogram Using Imaging Features to Predict Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ.
    Choi BH; Kang S; Cho N; Kim SY
    Korean J Radiol; 2024 Oct; 25(10):876-886. PubMed ID: 39344545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
    Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
    J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology, treatment, and outcome in very young and older women with DCIS.
    Alvarado R; Lari SA; Roses RE; Smith BD; Yang W; Mittendorf EA; Arun BK; Lucci A; Babiera GV; Wagner JL; Caudle AS; Meric-Bernstam F; Hwang RF; Bedrosian I; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2012 Nov; 19(12):3777-84. PubMed ID: 22622473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
    Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
    Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
    Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
    Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype.
    VandenBussche CJ; Elwood H; Cimino-Mathews A; Bittar Z; Illei PB; Warzecha HN
    Hum Pathol; 2013 Nov; 44(11):2487-93. PubMed ID: 24029706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
    Bijker N; Peterse JL; Duchateau L; Julien JP; Fentiman IS; Duval C; Di Palma S; Simony-Lafontaine J; de Mascarel I; van de Vijver MJ
    J Clin Oncol; 2001 Apr; 19(8):2263-71. PubMed ID: 11304780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 2000 Aug; 24(8):1058-67. PubMed ID: 10935646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
    Woodard GA; Price ER
    AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
    Wahedna Y; Evans AJ; Pinder SE; Ellis IO; Blamey RW; Geraghty JG
    Eur J Cancer; 2001 Mar; 37(4):459-62. PubMed ID: 11267854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
    Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
    Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical and Pathologic Characteristics of Ductal Carcinoma in Situ Detected on Mammography versus Ultrasound Only in Asymptomatic Patients.
    Moon HJ; Kim EK; Kim MJ; Yoon JH; Park VY
    Ultrasound Med Biol; 2019 Jan; 45(1):68-77. PubMed ID: 30322671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.
    Rauch GM; Hobbs BP; Kuerer HM; Scoggins ME; Benveniste AP; Park YM; Caudle AS; Fox PS; Smith BD; Adrada BE; Krishnamurthy S; Yang WT
    Ann Surg Oncol; 2016 Feb; 23(2):482-9. PubMed ID: 26416712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.